Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1).
TAAR1
aggression
dopamine
frontal cortex
gene knockout
grooming
resident-intruder
serotonin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
19
10
2022
revised:
08
11
2022
accepted:
10
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
The Trace Amine-Associated Receptor 1 (TAAR1) is one of the six functional receptors belonging to the family of monoamine-related G protein-coupled receptors (TAAR1-TAAR9) found in humans. However, the exact biological mechanisms of TAAR1 central and peripheral action remain to be fully understood. TAAR1 is widely expressed in the prefrontal cortex and several limbic regions, interplaying with the dopamine system to modulate the reward circuitry. Recent clinical trials suggest the efficacy of TAAR1 agonists as potential novel antipsychotic agents. Here, we characterize behavioral and neurochemical phenotypes of TAAR1 knockout mice, focusing on aggression and self-grooming behavior that both strongly depend on the monoaminergic signaling and cortico-striatal and cortico-limbic circuits. Overall, we report increased aggression in these knockout mice in the resident-intruder test, accompanied by reduced self-grooming behavior in the novelty-induced grooming test, and by higher cortical serotonin (5-HT) tissue levels. Further studies are necessary to explore whether TAAR1-based therapies can become potential novel treatments for a wide range of neuropsychiatric disorders associated with aggression.
Identifiants
pubmed: 36430544
pii: ijms232214066
doi: 10.3390/ijms232214066
pmc: PMC9695497
pii:
doi:
Substances chimiques
Receptors, G-Protein-Coupled
0
Serotonin
333DO1RDJY
Trace amine-associated receptor 1
XMC8VP6RI2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : St. Petersburg State University Budgetary Funds
ID : 93018770
Organisme : St. Petersburg State University Budgetary Funds
ID : 93020614
Organisme : Resource Fund of Applied Genetics MIPT
ID : 075-15-2021-684
Références
Psychopharmacology (Berl). 2015 Jul;232(14):2429-41
pubmed: 25716307
Neuropsychopharmacology. 2015 Jan;40(1):88-112
pubmed: 25178408
J Neurosci. 1996 May 15;16(10):3444-58
pubmed: 8627378
Psychopharmacology (Berl). 2008 Apr;197(3):449-56
pubmed: 18193405
Science. 2017 Jul 14;357(6347):162-168
pubmed: 28706064
J Vis Exp. 2013 Jul 04;(77):e4367
pubmed: 23852258
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8485-90
pubmed: 21525407
Lancet. 1974 Jul 6;2(7871):52-3
pubmed: 4134443
Psychopharmacology (Berl). 2011 Feb;213(2-3):183-212
pubmed: 20938650
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71
pubmed: 11459929
J Affect Disord. 2020 Jul 1;272:440-451
pubmed: 32553388
Brain Sci. 2022 May 08;12(5):
pubmed: 35625001
FASEB J. 2020 Aug;34(8):10887-10906
pubmed: 32609392
Psychiatr Danub. 2013 Mar;25(1):24-33
pubmed: 23470603
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9474-5
pubmed: 11504935
Nat Commun. 2021 Nov 23;12(1):6796
pubmed: 34815379
Int J Mol Sci. 2022 Jul 15;23(14):
pubmed: 35887159
Behav Brain Res. 2008 Jun 3;189(2):263-72
pubmed: 18281105
Neuropharmacology. 2014 Jun;81:283-91
pubmed: 24565640
Mol Pharmacol. 2001 Dec;60(6):1181-8
pubmed: 11723224
Clin Psychopharmacol Neurosci. 2019 Nov 20;17(4):475-486
pubmed: 31671484
Neuropharmacology. 2019 Jul 15;153:134-141
pubmed: 31078489
Bull Exp Biol Med. 2016 Mar;160(5):605-9
pubmed: 27021111
Front Psychiatry. 2020 Dec 03;11:599828
pubmed: 33343427
Drug Alcohol Depend. 2016 Feb 01;159:9-16
pubmed: 26644139
Int J Mol Sci. 2021 Dec 07;22(24):
pubmed: 34947997
Pharmacol Ther. 2017 Dec;180:161-180
pubmed: 28723415
Nat Rev Neurosci. 2016 Jan;17(1):45-59
pubmed: 26675822
Behav Pharmacol. 2011 Apr;22(2):136-46
pubmed: 21301323
Mol Neurobiol. 2011 Dec;44(3):449-64
pubmed: 22076606
Neuropharmacology. 2015 Jun;93:308-13
pubmed: 25721394
J Clin Psychiatry. 2010 Sep;71(9):1145-52
pubmed: 20361896
Eur Neuropsychopharmacol. 2015 Nov;25(11):2049-61
pubmed: 26372541
Cell Mol Neurobiol. 2020 Mar;40(2):273-282
pubmed: 31399838
Cogn Affect Behav Neurosci. 2015 Jun;15(2):460-74
pubmed: 25650085
PLoS One. 2013 Aug 01;8(8):e70274
pubmed: 23936403
Aggress Violent Behav. 2008 Oct;13(5):383-395
pubmed: 19802333
Front Pharmacol. 2018 Sep 04;9:953
pubmed: 30233365
Front Pharmacol. 2018 Jan 10;8:987
pubmed: 29375386
J Neurosci. 2018 Jul 18;38(29):6505-6512
pubmed: 29967006
Nat Neurosci. 2021 Nov;24(11):1586-1600
pubmed: 34663958
CNS Drugs. 2021 Nov;35(11):1153-1161
pubmed: 34655036
Front Pharmacol. 2018 Mar 12;9:222
pubmed: 29593543
Pharmacol Rev. 2018 Jul;70(3):549-620
pubmed: 29941461
Neuropsychopharmacology. 2017 May;42(6):1305-1314
pubmed: 27658486